Related references
Note: Only part of the references are listed.Association between pathological and MRI findings in multiple sclerosis
Massimo Filippi et al.
LANCET NEUROLOGY (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution
M. Filippi et al.
NEUROLOGY (2011)
Reducing the Impact of White Matter Lesions on Automated Measures of Brain Gray and White Matter Volumes
Declan T. Chard et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis
Maria Assunta Rocca et al.
RADIOLOGY (2010)
Gray matter atrophy in multiple sclerosis: A longitudinal study
Elizabeth Fisher et al.
ANNALS OF NEUROLOGY (2008)
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions
Jacqueline T. Chen et al.
ANNALS OF NEUROLOGY (2008)
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
G. Comi et al.
LANCET (2008)
Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
D. Bar-Zohar et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Robert Zivadinov
NEUROLOGY (2007)
Localization of grey matter atrophy in early RRMS - A longitudinal study
Bertrand Audoin et al.
JOURNAL OF NEUROLOGY (2006)
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis
Federica Agosta et al.
BRAIN (2006)
Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis
HK Mathiesen et al.
ARCHIVES OF NEUROLOGY (2006)
The measurement and clinical relevance of brain atrophy in multiple sclerosis
RA Bermel et al.
LANCET NEUROLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis
W Brück
JOURNAL OF NEUROLOGY (2005)
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
C Polman et al.
NEUROLOGY (2005)
Voxel-based analysis of MTR images:: A method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis
B Audoin et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study
M Rovaris et al.
BRAIN (2003)
Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years
B Turner et al.
MULTIPLE SCLEROSIS (2003)
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher et al.
NEUROLOGY (2002)
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance
David H. Miller et al.
BRAIN (2002)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability
N De Stefano et al.
ARCHIVES OF NEUROLOGY (2001)
Share Paper
